Molecular basis of pituitary development and cytogenesis

Frontiers of Hormone Research

Volumn 32, Issue , 2004, Pages 1-19

  Asa, Sylvia L ^a,b,c   Ezzat, Shereen ^a,b,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c MOUNT SINAI HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH PROMOTOR; HYPOPHYSIS HORMONE; TRANSCRIPTION FACTOR;

ANIMAL; CELL DIFFERENTIATION; CELL DIVISION; CELL LINE; CYTOLOGY; GROWTH, DEVELOPMENT AND AGING; HUMAN; HYPOPHYSIS; METABOLISM; PHYSIOLOGY; REVIEW; SECRETION;

ANIMALS; CELL DIFFERENTIATION; CELL DIVISION; CELL LINE; GROWTH SUBSTANCES; HUMANS; PITUITARY GLAND; PITUITARY HORMONES; TRANSCRIPTION FACTORS;

EID: 4043097775     PISSN: 03013073     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000079035     Document Type: Article

References (125)

1. Asa SL: Tumors of the Pituitary Gland. Atlas of Tumor Pathology, Third Series, Fasc 22. Washington, Armed Forces Institute of Pathology, 1998.
2. Asa SL, Kovacs K: Functional morphology of the human fetal pituitary. Pathology Annual 1984; 19: 275-315.
3. Scully KM, Rosenfeld MG: Pituitary development: Regulatory codes in mammalian organogenesis. Science 2002; 295: 2231-2235.
4. Asa SL, Kovacs K, Laszlo FA, Domokos I, Ezrin C: Human fetal adenohypophysis. Histologic and immunocytochemical analysis. Neuroendocrinology 1986; 43: 308-316.
5. Asa SL, Kovacs K, Horvath E, Losinski NE, Laszlo FA, Domokos I, Halliday WC: Human fetal adenohypophysis. Electron microscopic and ultrastructural immunocytochemical analysis. Neuroendocrinology 1988; 48: 423-431.
6. Asa SL, Kovacs K, Singer W: Human fetal adenohypophysis: Morphologic and functional analysis in vitro. Neuroendocrinology 1991; 53: 562-572.
7. Treier M, Gleiberman AS, O'Connell SM, Szeto DP, McMahon JA, McMahon AP, Rosenfeld MG: Multistep signaling requirements for pituitary organogenesis in vivo. Genes Dev 1998; 12: 1691-1704.
8. Ericson J, Norlin S, Jessell TM, Edlund T: Integrated FGF and BMP signaling controls the progression of progenitor cell differentiation and the emergence of pattern in the embryonic anterior pituitary. Development 1998; 125: 1005-1015.
9. Kimura S, Hara Y, Pineau T, Fernandez-Salguero P, Fox CH, Ward JM, Gonzalez FJ: The T/ebp null mouse: Thyroid-specific enhancer-binding protein is essential for the organogenesis of the thyroid, lung, ventral forebrain and pituitary. Genes Dev 1996; 10: 60-69.
10. Takuma N, Sheng HZ, Furuta Y, Ward JM, Sharma K, Hogan BL, Pfaff SL, Westphal H, Kimura S, Mahon KA: Formation of Rathke's pouch requires dual induction from the diencephalon. Development 1998; 125: 4835-4840.
11. De Moerlooze L, Spencer-Dene B, Revest J, Hajihosseini M, Rosewell I, Dickson C: An important role for the IIIb isoform of fibroblast growth factor receptor 2 (FGFR2) in mesenchymal-epithelial signalling during mouse organogenesis. Development 2000; 127: 483-492.
12. Celli G, LaRochelle WJ, Mackem S, Sharp R, Merlino G: Soluble dominant-negative receptor uncovers essential roles for fibroblast growth factors in multi-organ induction and patterning. EMBO J 1998; 17: 1642-1655.
13. Kioussi C, Briata P, Baek SH, Rose DW, Hamblet NS, Herman T, Ohgi KA, Lin C, Gleiberman A, Wang J, Brault Y Ruiz-Lozano P, Nguyen HD, Kemler R, Glass CK, Wynshaw-Boris A, Rosenfeld MG: Identification of a Wnt/Dvl/β-catenin → Pitx2 pathway mediating cell-type-specific proliferation during development. Cell 2002; 111: 673-685.
14. Lamonerie T, Tremblay JJ, Lanctot C, Therrien M, Gauthier Y, Drouin J: Ptxl, a bicoid-related homeobox transcription factor involved in transcription of the pro-opiomelanocortin gene. Genes Dev 1996; 10: 1284-1295.
15. Crawford MJ, Lanctot C, Tremblay JJ, Jenkins N, Gilbert D, Copeland N, Beatty B, Drouin J: Human and murine PTX1/Ptx1 gene maps to the region for Treacher Collins syndrome. Mamm Genome 1997; 8: 841-845.
16. Tremblay JJ, Lanctot C, Drouin J: The pan-pituitary activator of transcription, Ptx1 (pituitary homeobox 1) acts in synergy with SF-1 and Pit-1 and is an upstream regulator of the Lim-homeodomain gene Lim3/Lhx3. Mol Endocrinol 1998; 12:428-441.
17. Szeto DP, Ryan AK, O'Connell SM, Rosenfeld MG: P-OTX: A PIT-1-interacting homeodomain factor expressed during anterior pituitary gland development. Proc Natl Acad Sci USA 1996; 93: 7706-7710.
18. Lanctot C, Moreau A, Chamberland M, Tremblay ML, Drouin J: Hindlimb patterning and mandible development require the Ptxl gene. Development 1999; 126: 1805-1810.
19. Gage PJ, Camper SA: Pituitary homeobox 2, a novel member of the bicoid-related family of homeobox genes, is a potential regulator of anterior structure formation. Hum Mol Genet 1997; 6: 457-464.
20. Lin CR, Kioussi C, O'Connell S, Briata P, Szeto D, Liu F, Izpisua-Belmonte JC, Rosenfeld MG: Pitx2 regulates lung asymmetry, cardiac positioning and pituitary and tooth morphogenesis. Nature 1999; 401: 279-282.
21. Dasen JS, Barbera JP, Herman TS, Connell SO, Olson L, Ju B, Tollkuhn J, Baek SH, Rose DW, Rosenfeld MG: Temporal regulation of a paired-like homeodomain repressor/TLE corepressor complex and a related activator is required for pituitary organogenesis. Genes Dev 2001; 15: 3193-3207.
22. Bach I, Rhodes SJ, Pearse RY Heinzel T, Gloss B, Scully KM, Sawchenko PE, Rosenfeld MG: P-Lim, a LIM homeodomain factor, is expressed during pituitary organ and cell commitment and synergizes with Pit-1. Proc Natl Acad Sci USA 1995; 92: 2720-2724.
23. Pfaff SL, Mendelsohn M, Stewart CL, Edlund T, Jessell TM: Requirement for LIM homeobox gene Is11 in motor neuron generation reveals a motor neuron-dependent step in interneuron differentiation. Cell 1996; 84: 309-320.
24. Sheng HZ, Moriyama K, Yamashita T, Li H, Potter SS, Mahon KA, Westphal H: Multistep control of pituitary organogenesis. Science 1997; 278: 1809-1812.
25. Hermesz E, Machem S, Mahon KA: Rpx: A novel anterior-restricted homeobox gene progressively activated in the prechordal plate, anterior neural plate and Rathke's pouch of the mouse embryo. Development 1996; 122: 41-52.
26. Moncrieff MW, Hill DS, Archer J, Arthur LJH: Congenital absence of pituitary gland and adrenal hypoplasia. Arch Dis Child 1972; 47: 136-137.
27. Kauschansky A, Genel M, Walker Smith GJ: Congenital hypopituitarism in female infants. Its association with hypoglycemia and hypothyroidism. Am J Dis Child 1979; 133: 165-169.
28. Kosaki K, Matsuo N, Tamai S, Miyama S, Momoshima S: Isolated aplasia of the anterior pituitary as a cause of congenital panhypopituitarism. Horm Res 1991; 35: 226-228.
29. Pholsena M, Young J, Couzinet B, Schaison G: Primary adrenal and thyroid insufficiencies associated with hypopituitarism: A diagnostic challenge. Clin Endocrinol (Oxf) 1994; 40: 693-695.
30. Dattani MT, Martinez-Barbera JP, Thomas PQ, Brickman JM, Toresson H, Fox M, Hindmarsh PC, Krauss S, Robinson IC: Mutations in the homeobox gene HESX1/Hesx1 associated with septo-optic dysplasia in human and mouse. Nat Genet 1998; 19: 125-133.
31. Sornson MW, Wu W, Dasen JS, Flynn SE, Norman DJ, O'Connell SM, Gukovsky I, Carriere C, Ryan AK, Miller AP, Zuo L, Glieberman AS, Andersen B, Beamer WG, Rosenfeld MG: Pituitary lineage determination by the Prophet of Pit-1 homeodomain factor defective in Ames dwarfism. Nature 1996; 384: 327-333.
32. Gage PJ, Brinkmeier ML, Scarlett LM, Knapp LT, Camper SA, Mahon KA: The Ames dwarf gene, df, is required early in pituitary ontogeny for the extinction of Rpx transcription and initiation of lineage-specific cell proliferation. Mol Endocrinol 1996; 10: 1570-1581.
33. Wu W, Cogan JD, Pläffle RW, Dasen JS, Frisch H, O'Connell SM, Flynn SE, Brown MR, Mullis PE, Parks JS, Phillips JAI, Rosenfeld MG: Mutations in PROP1 cause familial combined pituitary hormone deficiency. Nat Genet 1998; 18: 147-149.
34. Fofanova O, Takmura N, Kinoshita E, Parks JS, Brown MR, Peterkova VA, Evgrafov OV, Goncharov NP, Bulatov AA, Dedov II, Yamashita S: Compound heterozygous deletion of the prop-1 gene in children with combined pituitary hormone deficiency. J Clin Endocrinol Metab 1998;83:2601-2604.
35. Brinkmeier ML, Potok MA, Cha KB, Gridley T, Stifani S, Meeldijk J, Clevers H, Camper SA: TCF4 and groucho-related genes influence pituitary growth and development. Mol Endocrinol 2003;17:2152-2161.
36. Bentley CA, Zidehsarai MP, Grindley JC, Parlow AF, Barth-Hall S, Roberts VJ: Pax6 is implicated in murine pituitary endocrine function. Endocrine 1999;10:171-177.
37. Hill ME, Asa SL, Drucker DJ: Essential requirement for Pax6 in control of enteroendocrine proglucagon gene transcription. Mol Endocrinol 1999;13:1474-1486.
38. Kioussi C, O'Connell S, St Onge L, Treier M, Gleiberman AS, Gruss P, Rosenfeld MG: Pax6 is essential for establishing ventral-dorsal cell boundaries in pituitary gland development. Proc Natl Acad Sci USA 1999;96:14378-14382.
39. Gallardo ME, Lopez-Rios J, Fernaud-Espinosa I, Granadino B, Sanz R, Ramos C, Ayuso C, Seller MJ, Brunner HG, Bovolenta P, Rodriguez DC: Genomic cloning and characterization of the human homeobox gene SIX6 reveals a cluster of SIX genes in chromosome 14 and associates SIX6 hemizygosity with bilateral anophthalmia and pituitary anomalies. Genomics 1999;61:82-91.
40. Jackson SM, Barnhart KM, Mellon P, Gutierrez-Hartmann A, Hoeffler JP: Helix-loop proteins are present and differentially expressed in different cell lines from the anterior pituitary. Mol Cell Endocrinol 1993;96:167-176.
41. Lamolet B, Pulichino AM, Lamonerie T, Gauthier Y, Brue T, Enjalbert A, Drouin J: A pituitary cell-restricted T box factor, Tpit, activates POMC transcription in cooperation with Pitx homeoproteins. Cell 2001;104:849-859.
42. Therrien M, Drouin J: Cell-specific helix-loop-helix factor required for pituitary expression of the pro-opiomelanocortin gene. Mol Cell Biol 1993;13:2342-2353.
43. Poulin G, Turgeon B, Drouin J: NeuroD1/β2 contributes to cell-specific transcription of the proopiomelanocortin gene. Mol Cell Biol 1997;17:6673-6682.
44. Ingraham HA, Chen R, Mangalam HJ, Elsholtz HP, Flynn SE, Lin CR, Simmons DM, Swanson L, Rosenfeld MG: A tissue-specific transcription factor containing a homeodomain specifies a pituitary phenotype. Cell 1988;55:519-529.
45. Bodner M, Castrillo JL, Theill LE, Deerinck T, Ellisman M, Karin M: The pituitary-specific transcription factor GHF-1 is a homeobox-containing protein. Cell 1988;55:505-518.
46. Ingraham HA, Albert VR, Chen R, Crenshaw EB III, Elsholtz HP, He X, Kapiloff MS, Mangalam HJ, Swanson LW, Treacy MN, Rosenfeld MG: A family of POU-domain and Pit-1 tissue-specific transcription factors in pituitary and neuroendocrine development. Annu Rev Physiol 1990;52: 773-791.
47. Rosenfeld MG: POU-domain transcription factors: Pou-er-ful developmental regulators. Genes Dev 1991;5:897-907.
48. Dollé P, Castrillo JL, Theill LE, Deerinck T, Ellisman M, Karin M: Expression of GHF-1 protein in mouse pituitaries correlates both temporally and spatially with the onset of growth hormone gene activity. Cell 1990;60:809-820.
49. Simmons DM, Voss JW, Ingraham HA, Holloway JM, Broide RS, Rosenfeld MG, Swanson LW: Pituitary cell phenotypes involve cell-specific Pit-1 mRNA translation and synergistic interactions with other classes of transcription factors. Genes Dev 1990;4:695-711.
50. Crenshaw EB III, Kalla K, Simmons DM, Swanson LW, Rosenfeld MG: Cell-specific expression of the prolactin gene in transgenic mice is controlled by synergistic interactions between promoter and enhancer elements. Genes Dev 1989;3:959-972.
51. Steinfelder HJ, Radovick S, Wondisford FE: Hormonal regulation of the thyrotropin 5-subunit gene by phosphorylation of the pituitary-specific transcription factor Pit-1. Proc Natl Acad Sci USA 1992;89:5942-5945.
52. Mason ME, Friend KE, Copper J, Shupnik MA: Pit-1/GHF-1 binds to TRH-sensitive regions of the rat thyrotropin n gene. Biochemistry 1993;32:8932-8938.
53. Kim MK, McClaskey JH, Bodenner DL, Weintraub BD: An AP-1-like factor and the pituitaryspecific factor Pit-1 are both necessary to mediate hormonal induction of human thyrotropin 5 gene expression. J Biol Chem 1993;268:23366-23375.
54. Drolet DW, Scully KM, Simmons DM, Wegner M, Chu K, Swanson LW, Rosenfeld MG: TEF, a transcription factor expressed specifically in the anterior pituitary during embryogenesis, defines a new class of leucine zipper proteins. Genes Dev 1991;5:1739-1753.
55. Konzak KE, Moore DD: Functional isoforms of Pit-1 generated by alternative messenger RNA splicing. Mol Endocrinol 1992;6:241-247.
56. Theill LE, Hattori K, Lazzaro D, Castrillo JL, Karin M: Differential splicing of the GHF-1 primary transcript gives rise to two functionally distinct homeodomain proteins. EMBO J 1992;11: 2261-2269.
57. Morris AE, Kloss B, McChesney RE, Bancroft C, Chasin LA: An alternatively spliced Pit-1 isoform altered in its ability to trans-activate. Nucleic Acids Res 1992;20:1355-1361.
58. Haugen BR, Wood WM, Gordon DF, Ridgway EC: A thyrotrope-specific variant of Pit-1 transactivates the thyrotropin promoter. J Biol Chem 1993;268:818-824.
59. Haugen BR, Gordon DF, Nelson AR, Wood WM, Ridgway EC: The combination of Pit-1 and Pit-1T have a synergistic stimulatory effect on the thyrotropin 5-subunit promoter but not the growth hormone or prolactin promoters. Mol Endocrinol 1994;8:1574-1582.
60. Scully KM, Jacobson EM, Jepsen K, Lunyak V, Viadiu H, Carriere C, Rose DW, Hooshmand F, Aggarwal AK, Rosenfeld MG: Allosteric effects of Pit-1 DNA sites on long-term repression in cell type specification. Science 2000;290:1127-1131.
61. Asa SL, Puy LA, Lew AM, Sundmark VC, Elsholtz HP: Cell type-specific expression of the pituitary transcription activator Pit-1 in the human pituitary and pituitary adenomas. J Clin Endocrinol Metab 1993;77:1275-1280.
62. Friend KE, Chiou YK, Laws ER Jr, Lopes MBS, Shupnik MA: Pit-1 messenger ribonucleic acid is differentially expressed in human pituitary adenomas. J Clin Endocrinol Metab 1993;77: 1281-1286.
63. Pellegrini I, Barlier A, Gunz G, Figarella-Branger D, Enjalbert A, Grisoli F, Jaquet P: Pit-1 gene expression in the human pituitary and pituitary adenomas. J Clin Endocrinol Metab 1994;79: 189-196.
64. Puy LA, Asa SL: The ontogeny of pit-1 expression in the human fetal pituitary gland. Neuroendocrinology 1996;63:349-355.
65. Li S, Crenshaw EB III, Rawson EJ, Simmons DM, Swanson LW, Rosenfeld MG: Dwarf locus mutants lacking three pituitary cell types result from mutations in the POU-domain gene pit-1. Nature 1990;347:528-533.
66. Tatsumi K, Miyai K, Notomi T, Kaibe K, Amino N, Mizuno Y, Kohno H: Cretinism with combined hormone deficiency caused by a mutation in the Pit-1 gene. Nat Genet 1992;1:56-58.
67. Pfäffle RW, DiMattia GE, Parks JS, Brown MR, Wit JM, Jansen M, van der Nat H, van den Brande JL, Rosenfeld MG, Ingraham HA: Mutation of the POU-specific domain of Pit-1 and hypopituitarism without pituitary hypoplasia. Science 1992;257:1118-1121.
68. Radovick S, Nations M, Du Y, Berg LA, Weintraub BD, Wondisford FE: A mutation in the POU-homeodomain of Pit-1 responsible for combined pituitary hormone deficiency. Science 1992;257: 1115-1118.
69. Lipkin SM, Naar AM, Kalla KA, Sack RA, Rosenfeld MG: Identification of a novel zinc finger protein binding a conserved element critical for Pit-1-dependent growth hormone gene expression. Genes Dev 1993;7:1674-1687.
70. Day RN, Koike S, Sakai M, Muramatsu M, Maurer RA: Both Pit-1 and the estrogen receptor are required for estrogen responsiveness of the rat prolactin gene. Mol Endocrinol 1990;4:1964-1971.
71. Stumpf WE, Sar M: Autoradiographic localization of estrogen, androgen, progestin and glucocorticosteroid in target tissues and non-target tissues; in Pasqualini JR (ed): Receptors and Mechanism of Action of Steroid Hormone, ed 8. New York, Dekker, 1976, pp 41-84.
72. Keefer DA, Stumpf WE, Petrusz P: Quantitative autoradiographic assessment of 3H-estradiol uptake in immunocytochemically characterized pituitary cells. Cell Tissue Res 1976;166:25-35.
73. Stefaneanu L, Kovacs K: Immunocytochemistry approach to demonstrate the estrogen receptor in human adenohypophyses and pituitary adenomas with monoclonal antibody. Med Sci Res 1988;16:449-450.
74. Zafar M, Ezzat S, Ramyar L, Pan N, Smyth HS, Asa SL: Cell-specific expression of estrogen receptor in the human pituitary and its adenomas. J Clin Endocrinol Metab 1995;80:3621-3627.
75. Friend KE, Chiou YK, Lopes MBS, Laws ER Jr, Hughes KM, Shupnik MA: Estrogen receptor expression in human pituitary: Correlation with immunohistochemistry in normal tissue, and immunohistochemistry and morphology in macroadenomas. J Clin Endocrinol Metab 1994;78: 1497-1504.
76. Losinski NE, Horvath E, Kovacs K, Asa SL: Immunoelectron microscopic evidence of mammosomatotrophs in human adult and fetal adenohypophyses, rat adenohypophyses and human and rat pituitary adenomas. Anat Anz 1991;172:11-16.
77. Nakao H, Koga M, Arao M, Nakao M, Sato B, Kishimoto S, Saitoh Y, Arita N, Mori S: Enzyme immunoassay for estrogen receptors in human pituitary adenomas. Acta Endocrinol (Copenh) 1989;120:233-238.
78. Ironside JW, Dangerfield VJM, Timperley WR, Underwood JCE: Steroid hormone receptors in pituitary adenomas: A biochemical, immunohistochemical and morphometric study on cryostat sections. Neuropathol Appl Neurobiol 1986;12:539-546.
79. Chaidarun SS, Klibanski A, Alexander JM: Tumor-specific expression of alternatively spliced estrogen receptor messenger ribonucleic acid variants in human pituitary adenomas. J Clin Endocrinol Metab 1997;82:1058-1065.
80. Simard J, Hubert JF, Hosseinzadeh T, Labrie F: Stimulation of growth hormone release and synthesis in rat anterior pituitary cells in culture. Endocrinology 1986;119:2004-2011.
81. Behringer RR, Mathews LS, Palmiter RD, Brinster RL: Dwarf mice produced by genetic ablation of growth hormone-expressing cells. Genes Dev 1988;2:453-461.
82. Borrelli E, Heyman RA, Arias C, Sawchenko PE, Evans RM: Transgenic mice with inducible dwarfism. Nature 1989;339:538-541.
83. Frawley LS, Boockfor FR, Hoeffler JP: Identification by plaque assays of a pituitary cell type that secretes both growth hormone and prolactin. Endocrinology 1985;116:734-737.
84. Frawley LS: Mammosomatotropes: Current status and possible functions. Trends Endocrinol Metab 1989;1:31-34.
85. Stefaneanu L, Kovacs K, Lloyd RV, Scheithauer BW, Young WF Jr, Sano T, Jin L: Pituitary lactotrophs and somatotrophs in pregnancy: A correlative in situ hybridization and immunocytochemical study. Virchows Arch B 1992;62:291-296.
86. Asa SL, Ezzat S: Pituitary transcription factors and cytodifferentiation in the human fetus (abstract). Ann Endocrinol (Paris) 1997;58:1S79.
87. Couse JF, Curtis SW, Washburn TF, Eddy EM, Schomberg DW, Korach KS: Disruption of the mouse oestrogen receptor gene: Resulting phenotypes and experimental findings. Biochem Soc Trans 1995;23:929-935.
88. Lubahn DB, Moyer JS, Golding TS, Couse JF, Korach KS, Smithies O: Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene. Proc Natl Acad Sci USA 1993;90:11162-11166.
89. Scully KM, Glieberman AS, Lindzey J, Lubahn DB, Korach KS, Rosenfeld MG: Role of estrogen receptor-α in the anterior pituitary gland. Mol Endocrinol 1997;11:674-681.
90. Smith EP, Boyd J, Frank GR, Takahashi H, Cohen RM, Speciker B, Williams TC, Lubahn DB, Korach KS: Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N Engl J Med 1994;331:1056-1061.
91. Enmark E, Pelto-Huikko M, Grandien K, Lagercrantz S, Lagercrantz J, Fried G, Nordenskjöd M, Gustafsson JA: Human estrogen receptor β-gene structure, chromosomal localization and expression pattern. J Clin Endocrinol Metab 1997;82:4258-4265.
92. MacLeod K, LePrince D, Stehelin D: The ets gene family. Trends Biochem Sci 1992;17:251-256.
93. Bradford AP, Conrad KE, Wasylyk C, Wasylyk B, Gutierrez-Hartmann A: Functional interaction of c-Ets-1 and GHF-1/Pit-1 mediates Ras activation of pituitary-specific gene expression: Mapping of the essential c-Ets-1 domain. Mol Cell Biol 1995;15:2849-2857.
94. Horvath E, Lloyd RV, Kovacs K: Propylthiouracyl-induced hypothyroidism results in reversible transdifferentiation of somatotrophs into thyroidectomy cells. A morphologic study of the rat pituitary including immunoelectron microscopy. Lab Invest 1990;63:511-520.
95. Dasen JS, O'Connell SM, Flynn SE, Treier M, Gleiberman AS, Szeto DP, Hooshmand F, Aggarwal AK, Rosenfeld MG: Reciprocal interactions of Pit1 and GATA2 mediate signaling gradient-induced determination of pituitary cell types. Cell 1999;97:587-598.
96. Lala DS, Rice DA, Parker KL: Steroidogenic factor I a key regulator of steroidogenic enzyme expression is the mouse homolog of fushi tarazu-factor I. Mol Endocrinol 1992;6:1249-1258.
97. Morohashi KI, Honda SI, Inomata Y, Handa H, Omura T: A common trans-acting factor, Ad4-binding protein, to the promoters of steroidogenic P-450s. J Biol Chem 1992;267:17913-17919.
98. Honda SI, Morohashi KI, Nomura M, Takeya H, Kitajima M, Omura T: Ad4BP regulating steroidogenic P-450 gene is a member of steroid hormone receptor superfamily. J Biol Chem 1993;268: 7494-7502.
99. Ikeda Y, Lala DS, Luo X, Kim E, Moisan MP, Parker KL: Characterization of the mouse FTZ-F1 gene which encodes a key regulator of steroid hydroxylase gene expression. Mol Endocrinol 1993;7: 852-860.
100. Morohashi KI, Zanger UM, Honda SI, Hara M, Waterman MR, Omura T: Activation of CYP11A and CYP11B gene promoters by the steroidogenic cell-specific transcription factor, Ad4BP. Mol Endocrinol 1993;7:1196-1204.
101. Morohashi KI, Iida H, Nomura M, Hatano O, Honda SI, Tsukiyama T, Niwa O, Hara T, Takakusu A, Shibata Y, Omura T: Functional difference between Ad4BP and ELP and their distributions in steroidogenic tissues. Mol Endocrinol 1994;8:643-653.
102. Ikeda Y, Shen WH, Ingraham HA, Parker KL: Developmental expression of mouse steroidogenic factor-1, an essential regulator of the steroid hydroxylases. Mol Endocrinol 1994;8:654-662.
103. Shen WH, Moore CCD, Ikeda Y, Parker KL, Ingraham HA: Nuclear receptor steroidogenic factor 1 regulates the müllerian inhibiting substance gene: A link to the sex determination cascade. Cell 1994;77:651-661.
104. Luo X, Ikeda Y, Parker KL: A cell-specific nuclear receptor is essential for adrenal and gonadal development and sexual differentiation. Cell 1994;77:481-490.
105. Ingraham HA, Lala DS, Ikeda Y, Luo X, Shen WH, Nachtigal MW, Abbud R, Nilson JH, Parker KL: The nuclear receptor steroidogenic factor 1 acts at multiple levels of the reproductive axis. Genes Dev 1994;8:2302-2312.
106. Ikeda Y, Luo X, Abbud R, Nilson JH, Parker KL: The nuclear receptor steroidogenic factor 1 is essential for the formation of the ventromedial hypothalamic nucleus. Mol Endocrinol 1995;9: 478-486.
107. Barnhart KM, Mellon PL: The orphan nuclear receptor, steroidogenic factor-1, regulates the glycoprotein hormone α-subunit gene in pituitary gonadotropes. Mol Endocrinol 1994;8:878-885.
108. Asa SL, Bamberger AM, Cao B, Wong M, Parker KL, Ezzat S: The transcription activator steroidogenic factor-1 is preferentially expressed in the human pituitary gonadotroph. J Clin Endocrinol Metab 1996;81:2165-2170.
109. Ikuyama S, Ohe K, Sakai Y, Nakagaki H, Fukushima T, Kato Y, Morohashi K, Takayanagi R, Nawata H: Follicle-stimulating hormone-β subunit gene is expressed in parallel with a transcription factor Ad4BP/SF-1 in human pituitary adenomas. Clin Endocrinol (Oxf) 1996;45:187-193.
110. Asa SL, Gerrie BM, Singer W, Horvath E, Kovacs K, Smyth HS: Gonadotropin secretion in vitro by human pituitary null cell adenomas and oncocytomas. J Clin Endocrinol Metab 1986;62:1011-1019.
111. Yamada S, Asa SL, Kovacs K, Muller P, Smyth HS: Analysis of hormone secretion by clinically nonfunctioning human pituitary adenomas using the reverse hemolytic plaque assay. J Clin Endocrinol Metab 1989;68:73-80.
112. Yamada S, Asa SL, Kovacs K: Oncocytomas and null cell adenomas of the human pituitary: Morphometric and in vitro functional comparison. Virchows Arch A 1988;413:333-339.
113. Asa SL, Cheng Z, Ramyar L, Singer W, Kovacs K, Smyth HS, Muller P: Human pituitary null cell adenomas and oncocytomas in vitro: Effects of adenohypophysiotropic hormones and gonadal steroids on hormone secretion and tumor cell morphology. J Clin Endocrinol Metab 1992;74: 1128-1134.
114. Kumar TR, Graham KE, Asa SL, Low MJ: Simian virus 40 T antigen-induced gonadotroph adenomas: A model of human null cell adenomas. Endocrinology 1998;139:3342-3351.
115. Chaidarun SS, Eggo MC, Stewart PM, Barber PC, Sheppard MC: Role of growth factors and estrogen as modulators of growth differentiation and expression of gonadotropin subunit genes in primary cultured sheep pituitary cells. Endocrinology 1994;134:935-944.
116. Gharib SD, Wierman ME, Shupnik MA, Chin WW: Molecular biology of the pituitary gonadotropins. Endocr Rev 1990;11:177-198.
117. Shupnik MA, Gharib SD, Chin WW: Divergent effects of estradiol on gonadotropin gene transcription in pituitary fragments. Mol Endocrinol 1989;3:474-480.
118. Shupnik MA, Weinmann CM, Notides AC, Chin WW: An upstream region of the rat luteinizing hormone 1 gene binds estrogen receptor and confers estrogen responsiveness. J Biol Chem 1989;264: 80-86.
119. McCormick A, Brady H, Theill LE, Karin M: Regulation of the pituitary-specific homeobox gene GHF-1 by cell-autonomous and environmental cues. Nature 1990;345:829-832.
120. Theill LE, Karin M: Transcriptional control of GH expression and anterior pituitary development. Endocr Rev 1993;14:670-689.
121. Delegeane AM, Ferland LH, Mellon P: Tissue-specific enhancer of the human glycoprotein hormone α-subunit gene: Dependence on cyclic AMP-inducible elements. Mol Cell Biol 1987;7: 3994-4002.
122. Struthers RS, Vale WW, Arias C, Sawchenko PE, Montminy MR: Somatotroph hypoplasia and dwarfism in transgenic mice expressing a non-phosphorylatable CREB mutant. Nature 1991;350: 622-624.
123. Asa SL: The role of hypothalamic hormones in the pathogenesis of pituitary adenomas. Pathol Res Pract 1991;187:581-583.
124. Pilavdzic D, Kovacs K, Asa SL: Pituitary morphology in anencephalic human fetuses. Neuroendocrinology 1997;65:164-172.
125. Batt J, Asa S, Fladd C, Rotin D: Pituitary pancreatic and gut neuroendocrine defects in protein tyrosine phosphatase-σ-deficient mice. Mol Endocrinol 2002;16:155-169.